Related Experiment Video
Updated: Apr 19, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
Cucurbitacin-B inhibits neuroblastoma cell proliferation through up-regulation of PTEN
1Department of Neonatology, First Affiliated Hospital of Xinxiang Medical College, Henan, China. shujunLi01@126.com.
Objective:
Cucurbitacins belong to a class of highly oxidized tetracyclic triterpenoids. Recent studies suggest that the use of Cucurbitacin could repress cancer cell progression. However, the biological effect of Cucurbitacin-B in neuroblastoma cells remains unexplored.
Materials And Methods:
MTT and BrdU (bromodeoxyuridine) incorporation assays were used to determine the anti-proliferation roles of Cucurbitacin-B. Real-time PCR and Western blot assays were used to detect the expression of cell cycle regulators. Small interfering RNAs (siRNAs) were used to silence the expression of PTEN (phosphatase and tensin homolog gene).
Results:
We found that Cucurbitacin-B inhibited growth and modulated expression of cell-cycle regulators in SHSY5Y cells. At the molecular level, we found that Cucurbitacin-B inhibited AKT signaling activation through up-regulation of PTEN. Indeed, PTEN deficiency using siRNA oligos attenuated the anti-proliferative roles of Cucurbitacin-B.
Conclusions:
These results provide evidence for a mechanism that may contribute to the antineoplastic effects of Cucurbitacin-B in neuroblastoma.
Insights
Cucurbitacin-B inhibits neuroblastoma cell growth by up-regulating PTEN and down-regulating AKT signaling. This discovery offers a potential therapeutic strategy for neuroblastoma treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Cucurbitacins are triterpenoids with potential anticancer properties.
- The specific effects of Cucurbitacin-B on neuroblastoma cells are not well understood.
Purpose of the Study:
- To investigate the anti-proliferative effects of Cucurbitacin-B in neuroblastoma cells.
- To elucidate the molecular mechanisms underlying Cucurbitacin-B's action.
Main Methods:
- Cell proliferation was assessed using MTT and BrdU incorporation assays.
- Gene and protein expression of cell cycle regulators were analyzed via Real-time PCR and Western blot.
- PTEN (phosphatase and tensin homolog) gene expression was modulated using small interfering RNAs (siRNAs).
Main Results:
- Cucurbitacin-B significantly inhibited neuroblastoma (SHSY5Y) cell growth.
- Cucurbitacin-B modulated the expression of key cell cycle regulators.
- The compound inhibited AKT signaling by up-regulating PTEN expression, and PTEN deficiency diminished its anti-proliferative effects.
Conclusions:
- Cucurbitacin-B exhibits anti-proliferative effects in neuroblastoma cells.
- The mechanism involves the up-regulation of PTEN, leading to the inhibition of AKT signaling.
- These findings suggest Cucurbitacin-B as a potential therapeutic agent for neuroblastoma.
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity
Inhibition of CDK Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
